samedan logo
 
 
spacer
home > pmps > autumn 2020 > rapid vaccine distribution to over 7.5 billion humans
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Rapid Vaccine Distribution to Over 7.5 Billion Humans

Who would have said a year ago that disruptions to supply chains, and more broadly, our way of life, would not come from a new company, a start-up, or a new economic model, but rather from a virus?

The disruption caused by COVID-19 has been extensive, we cannot control its spread, and we do not understand its behaviour. How it affects our health varies from person to person for unknown reasons, and may include mild symptoms, severe symptoms, or even asymptotic cases in individuals who spread the virus unknowingly.

The Race for a Vaccine is Underway

Over 193 vaccines are currently being trialled, 151 of which are in the pre-clinical phase, and over 42 of which have begun clinical trials (1). Over eight different types of vaccines are being trialled: messenger RNA (mRNA), DNA plasmid, protein subunit, adenovirus-vectored, measles-vectored, vesicular stomatitis virus-vectored, adenovirus associated-vectored, and inactivated virus vaccines.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Florence Lehec is Head of Marketing for EMBALL’ISO Group, its eight worldwide productions sites and 14 service hubs. Florence joined EMBALL’ISO three years ago. Besides her marketing and communication activities, she has worked on the development of the isothermal solution ‘reuse and reverse business model’ together with the sales team and the supply chain team. Before taking these responsibilities, she has held several sales and marketing positions for Air France. She is a graduate of ESSEC MBA, France.
spacer
Florence Lehec
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Syntegon and Vetter win PDA Drug Delivery Innovation Award for Versynta microBatch

Waiblingen/Germany, October 6, 2021. Together with Vetter, an international pharmaceutical service provider for injectables, Syntegon (formerly Bosch Packaging Technology) has won the PDA Drug Delivery Innovation Award. In the "Partnership Innovation" category, the Parental Drug Association (PDA) honors development projects by pharmaceutical and machine manufacturers that advance the production of (bio)pharmaceuticals. The collaboration between Vetter and Syntegon resulted in Versynta microBatch, a highly flexible and fully automated production cell with a gloveless isolator, the smallest possible dimensions and a complete batch-to-batch changeover of less than two hours.
More info >>

White Papers

Competitive Drive: The Challenges of a Globalised Packaging Industry

Aesica Pharmaceuticals

Packaging is becoming an increasingly competitive and lucrative industry globally. Jeremy Drummond PhD of Aesica Formulated Products looks at the challenges and opportunities this presents.
More info >>

 

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement